Abstract
The levels of expression of histocompatibility antigens on the cell membrane and their gene expression in non-metastatic and in highly metastatic Friend leukemia cells (FLC) were measured and the levels of expression of these antigens were correlated with the differentin vivo behaviour of the tumor cells. Highly metastaticin vivo passaged FLC (either interferon-sensitive 745 or interferonα/β-resistant 3Cl-8 cells) expressed higher levels of class I H-2K and H-2D antigens on their cell membrane with respect to the non-metastaticin vitro passaged counterparts. The increased expression of H-2 class I antigens was associated with an increased transcription of H-2K and H-2D genes. As bothin vitro andin vivo passaged FLC have been shown to be resistantin vitro to the natural killer (NK) cell activity, we tried to correlate the levels of expression of histocompatibility antigens with thein vivo clearance of [125I]UDR-labeled FLC. However, no correlation was found between the levels of expression of H-2 antigens and thein vivo clearance of tumor cells. In fact,in vivo passaged FLC (tested either after 1 or after 15in vitro passages) expressed virtually identical levels of H-2 antigens; however, the freshly explantedin vivo passaged FLC exhibited markedly lower levels of clearance from the lung, spleen and liver (when injected i.v. in DBA/2 mice) with respect to the corresponding FLC cultivated for several passagesin vitro. Pretreatment ofin vitro passaged 745 FLC with either interferonα/β or interferonγ resulted in the acquisition of some metastatic potential of FLC to the liver when interferon-treated FLC were subsequently injected i.v. in DBA/2 mice; suchin vitro treatments resulted in a 2–3-fold increase in the expression of H-2K antigensversus the control untreated FLC. We suggest that such increases could represent some advantages for the homing properties of tumor cells and/or for the tumor progression, by mechanisms different from the resistance to the NK cells.
Similar content being viewed by others
References
Affabris, E., Jemma, C., andRossi, G. B., 1982, Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain.Virology,120, 441–452.
Amici, C., Ferrantini, M., Benedetto, A., Belardelli, F., andGresser, I., 1984, Biologic and biochemical differences betweenin vitro and in vivo passaged Friend erythroleukemia cells. II. Changes in cell surface glycoproteins associated with a highly malignant phenotype.International Journal of Cancer,34, 397–402.
Avis, H., andLeder, P., 1972, Purification of biologically active globin mRNA by chromatography or oligo(dT)-cellulose.Proceedings of the National Academy of Sciences of the U.S.A.,69, 264–268.
Bartlett, P. F., andEdidin, M., 1978, Effect of the H-2 gene complex rates on fibroblast intercellular adhesion.Journal of Cell Biology,77, 377–388.
Becker, S., Kiessling, R., Lee, N., andKlein, G., 1978, Modulation of sensitivity to natural killer cell lysis afterin vitro explantation of mouse lymphoma.Journal of the National Cancer Institute,61, 1495–1498.
Belardelli, F., Gresser, I., Maury, C., Duvillard, P., Prade, M., andMaunoury, M. T., 1983, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously.International Journal of Cancer,31, 649–653.
Belardelli, F., Ferrantini, F., Maury, C., Santurbano, L., andGresser, I., 1984, Biologic and biochemical differences betweenin vitro andin vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize.International Journal of Cancer,34, 389–395.
Cikes, M., Friberg, S., andKlein, G., 1973, Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by moloney leukemia virus in cultured murine lymphomas.Journal of the National Cancer Institute,50, 347–362.
Curtis, A. S. G., andRooney, P., 1979, H-2 restriction of contact inhibition of epithelial cells.Nature,281, 222–223.
Curtis, A. S. G., andDavies, M. D. J., 1981, H-2D antigens released by thymocytes and cell adhesion.Journal of Immunogenetics,8, 367–377.
De Baetselier, P., Katzav, S., Gorelik, E., Feldman, M., andSegal, S., 1980, Differential expression of H-2 gene products in tumor cells in association with their metastatogenic properties.Nature,288, 179–181.
De Baetselier, P., Roos, E., Brys, L., Remels, L., andFeldman, M., 1984, Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma byin vivo fusion with normal cells.International Journal of Cancer,34, 731–738.
Doherty, P., Knowles, B., andWettstein, P. I., 1984, Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T-cell function.Advances in Cancer Research,42, 1–65.
Eisenbach, L., Segal, S., andFeldman, M., 1983, MHC imbalance and metastatic spread in Lewis lung carcinoma clones.International Journal of Cancer,32, 113–120.
Elia, G., Ferrantini, M., Belardelli, F., Proietti, E., Gresser, I., Amici, C., andBenedetto, A., 1988, Changes of wheat germ agglutinin, binding proteins in highly malignant Friend leukemia cells metastasizing to the liver.Clinical Experimental Metastasis,6, 347–362.
Ferrantini, M., Locardi, C., andBelardelli, F., 1988, Role of endogenous interferonα/β in the selection of virus-non-producers Friend leukemia cells after repeated intraperitoneal passages in syngeneic mice.Journal of Virology,62, 600–605.
Finn, O. L., Lieberman, M., andKaplan, H. S., 1978, H-2 antigen expression: lossin vitro, restorationin vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.Immunogenetics,7, 79–88.
Glisin, V., Crkvenjakov, R., andByus, C., 1974, Ribonucleic acid isolation by cesium chloride centrifugation.Biochemistry,13, 2633–2636.
Gooding, L. R., 1982, Characterization of a progressive tumor from C3H fibroblasts transformedin vitro with SV40 virus. Immunoresistancein vivo correlates with phenotypic loss of H-2Kk.Journal of Immunology,129, 1306–1312.
Goodnew, R. S., Vogel, J. M., andRichard, L. L., 1985, Histocompatibility antigens on murine tumors.Science,230, 777–783.
Gresser, I., Maury, C., Woodrow, D., Moss, J., Grütter, M. G., Vignaux, F., Belardelli, F., andMaunoury, M. T., 1988, Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.International Journal of Cancer,41, 135–142.
Haywood, G. R., andMcKhann, C. F., 1971, Antigenic specificities on murine sarcoma cells: reciprocal relationship between normal transplantation antigens (H-2) and tumor specific immunogenicity.Journal of Experimental Medicine,133, 1171–1187.
Holtkamp, B., Fisher-Lindahl, K., Segal, M., andRajewsky, K., 1979, Spontaneous loss and subsequent stimulation of H-2 expression in clones of a heterozygous lymphoma line.Immunogenetics,9, 405–421.
Jack, A. S., andMcVeigh, K., 1987, A demonstration of a strain related restriction effect in the formation of experimental metastasis.Journal of Pathology,152, 37–45.
Jones, J. M., andFeldman, J. D., 1975, Alloantigen expression of a rat moloney sarcoma.Journal of the National Cancer Institute,55, 995–999.
Karre, K., Ljunggren, H. G., Piontek, G., andKiessling, R., 1986, Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy.Nature,319, 675–678.
Katzav, S., Tartakovsky, B., De Baetselier, P., Isakov, N., Feldman, M., andSegal, S., 1983, H-2 and other major histocompatibility complexes.Translation Proceedings,15, 162–170.
Katzav, S., De Baetselier, P., Tartakovsky, B., Feldman, M., andSegal, S., 1983, Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from non metastatic to metastatic cells.Journal of the National Cancer Institute,71, 317–324.
Lalanne, J. L., Transy, C., Guerin, S., Darche, S., Meulien, P., andKourilsky, P., 1985, Expression of class I genes in the major histocompatibility complex: identification of eight distinct RNAs in DBA/2 mouse liver.Cell,41, 469–478.
Larizza, L., Schirrmacher, V., Graf, L., Pflunger, E., Prez-Martinez, M., andStohr, M., 1984, Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.International Journal of Cancer,34, 699–707.
Ljunggren, H. G., andKarre, K., 1985, Host resistance directed selectively against H-2 deficient lymphoma variants. Analysis of the mechanism.Journal of Experimental Medicine,162, 1745–1759.
Locardi, C., Belardelli, F., Federico, M., Romeo, G., Affabris, E., andGresser, I., 1987, Effect of mouse interferonα/β on the expression of H-2 (class I) antigens and on the levels of 2′,5′-oligoadenylate synthetase activity in interferon-sensitive and interferonresistant Friend leukemia cell tumors in mice.Journal of Biological Regulators and Homeostatic Agents,1, 189–194.
Mechti, N., Affabris, E., Romeo, G., Lebleu, B., andRossi, G. B., 1984, Role of interferon and 2,5A-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells.Journal of Biological Chemistry,259, 3261–3269.
Ramani, P., andBalkwill, F. R., 1987, Enhanced metastases of a mouse carcinoma afterin vitro treatment with murine interferon gamma.International Journal of Cancer,40, 830–834.
Riccardi, C., Santoni, A., Barlozzari, T., Puccetti, P., andHerberman, R. B., 1980,In vivo natural reactivity of mice against tumor cells.International Journal of Cancer,25, 475–486.
Schirrmacher, V., Cheinsong-Popov, R., andArnheiter, H., 1980, Hepatocytetumor cell interactionin vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody.Journal of Experimental Medicine,151, 984–989.
Schrier, P. I., Lieberman, M., andKaplan, H. S., 1978, Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells.Nature,305, 771–775.
Taniguchi, K., Petersson, M., Hoglund, P., Kiessling, R., Klein, G., andKarre, K., 1987, Interferonγ induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.Proceedings of the National Academy of Science of the U.S.A.,84, 3405–3409.
Thomas, P. S., 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences of the U.S.A.,77, 5201–5205.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrantini, M., Pulciani, S., Proietti, E. et al. Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with thein vivo behaviour of tumor cells. Clin Exp Metast 7, 609–625 (1989). https://doi.org/10.1007/BF01753672
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01753672